Annual Retained Earnings
-$108.27 M
-$12.47 M-13.02%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual retained earnings is -$108.27 million, with the most recent change of -$12.47 million (-13.02%) on December 31, 2023.
- During the last 3 years, NRBO annual retained earnings has fallen by -$41.72 million (-62.70%).
- NRBO annual retained earnings is now -18438.53% below its all-time high of -$584.00 thousand, reached on December 31, 2014.
Performance
NRBO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$130.68 M
-$5.65 M-4.52%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly retained earnings is -$130.68 million, with the most recent change of -$5.65 million (-4.52%) on September 30, 2024.
- Over the past year, NRBO quarterly retained earnings has dropped by -$22.42 million (-20.71%).
- NRBO quarterly retained earnings is now -954.58% below its all-time high of -$12.39 million, reached on December 31, 2015.
Performance
NRBO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NRBO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.0% | -20.7% |
| 3 y3 years | -62.7% | -69.2% |
| 5 y5 years | -596.1% | -38.6% |
NRBO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | at low | -59.7% | at low |
| 5 y | 5-year | -193.7% | at low | -254.5% | at low |
| alltime | all time | <-9999.0% | at low | -954.6% | at low |
NeuroBo Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$130.68 M(+4.5%) |
| Jun 2024 | - | -$125.03 M(+8.7%) |
| Mar 2024 | - | -$114.98 M(+6.2%) |
| Dec 2023 | -$108.27 M(+13.0%) | -$108.27 M(+5.2%) |
| Sep 2023 | - | -$102.95 M(+3.9%) |
| Jun 2023 | - | -$99.13 M(+0.7%) |
| Mar 2023 | - | -$98.40 M(+2.7%) |
| Dec 2022 | -$95.80 M(+17.1%) | -$95.80 M(+5.1%) |
| Sep 2022 | - | -$91.12 M(+3.5%) |
| Jun 2022 | - | -$88.01 M(+3.9%) |
| Mar 2022 | - | -$84.70 M(+3.5%) |
| Dec 2021 | -$81.83 M(+23.0%) | -$81.83 M(+5.9%) |
| Sep 2021 | - | -$77.25 M(+4.7%) |
| Jun 2021 | - | -$73.79 M(+5.6%) |
| Mar 2021 | - | -$69.87 M(+5.0%) |
| Dec 2020 | -$66.54 M | -$66.54 M(+41.5%) |
| Sep 2020 | - | -$47.03 M(+6.9%) |
| Jun 2020 | - | -$43.98 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$41.60 M(+12.8%) |
| Dec 2019 | -$36.87 M(+137.0%) | -$36.87 M(-60.9%) |
| Sep 2019 | - | -$94.26 M(+3.8%) |
| Jun 2019 | - | -$90.83 M(+3.3%) |
| Mar 2019 | - | -$87.91 M(+465.2%) |
| Dec 2018 | -$15.55 M(-74.3%) | -$15.55 M(-80.7%) |
| Sep 2018 | - | -$80.45 M(+8.2%) |
| Jun 2018 | - | -$74.38 M(+9.9%) |
| Mar 2018 | - | -$67.70 M(+11.9%) |
| Dec 2017 | -$60.47 M(+123.5%) | -$60.47 M(+12.6%) |
| Sep 2017 | - | -$53.73 M(+19.2%) |
| Jun 2017 | - | -$45.06 M(+30.4%) |
| Mar 2017 | - | -$34.55 M(+27.7%) |
| Dec 2016 | -$27.06 M(+118.4%) | -$27.06 M(+36.4%) |
| Sep 2016 | - | -$19.84 M(+24.3%) |
| Jun 2016 | - | -$15.97 M(+9.9%) |
| Mar 2016 | - | -$14.54 M(+17.3%) |
| Dec 2015 | -$12.39 M(+2021.9%) | -$12.39 M |
| Dec 2014 | -$584.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual retained earnings year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly retained earnings year-on-year change?
What is NeuroBo Pharmaceuticals annual retained earnings?
The current annual retained earnings of NRBO is -$108.27 M
What is the all time high annual retained earnings for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual retained earnings is -$584.00 K
What is NeuroBo Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, NRBO annual retained earnings has changed by -$12.47 M (-13.02%)
What is NeuroBo Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NRBO is -$130.68 M
What is the all time high quarterly retained earnings for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly retained earnings is -$12.39 M
What is NeuroBo Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NRBO quarterly retained earnings has changed by -$22.42 M (-20.71%)